Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study

Conclusions: Use of propanolol was associated with reduced mortality, compared with controls, in this nationwide cohort of patients with cirrhosis and refractory ascites.

Source: The Saudi Journal of Gastroenterology - March 16, 2022 Category: Gastroenterology Authors: Yen-Chun Chen Yun-Da Li Chia-Ming Lu Wei-Chun Huang Sung-Shuo Kao Wen-Chi Chen Source Type: research